Pan-Cancer Analyses Reveal Long Intergenic Non-Coding RNAs Relevant to Tumor Diagnosis, Subtyping and Prognosis

EBioMedicine

Volumn 7, Issue , 2016, Pages 62-72

  Ching, Travers ^a,b   Peplowska, Karolina ^b   Huang, Sijia ^a,b   Zhu, Xun ^a,b   Shen, Yi ^b   Molnar, Janos ^b   Yu, Herbert ^b   Tiirikainen, Maarit ^b   Fogelgren, Ben ^c   Fan, Rong ^d   Garmire, Lana X ^a,b  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d Yale University   (United States)

Author keywords

Biomarkers; LincRNA; LncRNA; Pan cancer; RNASeq

Indexed keywords

LONG UNTRANSLATED RNA; SMALL INTERFERING RNA; TUMOR MARKER;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER PROGNOSIS; CELL MIGRATION ASSAY; CELL PROLIFERATION; COLON ADENOCARCINOMA; COLON CANCER; GENE EXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA SEQUENCE; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL LUNG CARCINOMA; STOMACH ADENOCARCINOMA; THYROID CARCINOMA; TISSUE SPECIFICITY; TUMOR DIAGNOSIS; UPREGULATION; ANTIBODY SPECIFICITY; BREAST NEOPLASMS; CELL MOTION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; MCF-7 CELL LINE; PATHOLOGY; PROCEDURES; PROGNOSIS; SEQUENCE ANALYSIS; TUMOR CELL LINE;

BIOMARKERS, TUMOR; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; ORGAN SPECIFICITY; PROGNOSIS; RNA, LONG NONCODING; SEQUENCE ANALYSIS, RNA;

EID: 84962023190     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.03.023     Document Type: Article

References (50)

1. Berrar D., Bradbury I., Bubitzky W. Avoiding model selection bias in small-sample genomic datasets. Bioinformatics 2006, 22:1245-1250.
2. BROAD Broad Institute TCGA Genome Data Analysis Center (2014): Analysis Overview for 15 July 2014 2014, Broad Institute of MIT and Harvard.
3. Brockdorff N., Ashworth A., Kay G.F., Cooper P., Smith S., Mccabe V.M., Norris D.P., Penny G.D., Patel D., Rastan S. Conservation of position and exclusive expression of mouse xist from the inactive X chromosome. Nature 1991, 351:329-331.
4. Cabili M.N., Trapnell C., Goff L., Koziol M., Tazon-Vega B., Regev A., Rinn J.L. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011, 25:1915-1927.
5. Camacho C., Coulouris G., Avagyan V., Ma N., Papadopoulos J., Bealer K., Madden T.L. BLAST+: architecture and applications. BMC Bioinf. 2009, 10:421.
6. Cancer Genome Atlas N. Comprehensive molecular portraits of human breast tumours. Nature 2012, 490:61-70.
7. Cancer Genome Atlas Research N., Weinstein J.N., Collisson E.A., Mills G.B., Shaw K.R., Ozenberger B.A., Ellrott K., Shmulevich I., Sander C., Stuart J.M. The cancer genome atlas Pan-cancer analysis project. Nat. Genet. 2013, 45:1113-1120.
8. Ching T., Huang S., Garmire L.X. Power analysis and sample size estimation for RNA-seq differential expression. RNA 2014, 20:1684-1696.
9. Consortium E.P. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
10. Du Z., Fei T., Verhaak R.G., Su Z., Zhang Y., Brown M., Chen Y., Liu X.S. Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat. Struct. Mol. Biol. 2013, 20:908-913.
11. Garmire L.X., Garmire D.G., Huang W., Yao J., Glass C.K., Subramaniam S. A global clustering algorithm to identify long intergenic non-coding RNA-with applications in mouse macrophages. PLoS One 2011, 6.
12. Ge X., Chen Y., Liao X., Liu D., Li F., Ruan H., Jia W. Overexpression of long noncoding RNA PCAT-1 is a novel biomarker of poor prognosis in patients with colorectal cancer. Med. Oncol. 2013, 30:1-6.
13. Gupta R.A., Shah N., Wang K.C., Kim J., Horlings H.M., Wong D.J., Tsai M.-C., Hung T., Argani P., Rinn J.L. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464:1071-1076.
14. Habel L.A., Shak S., Jacobs M.K., Capra A., Alexander C., Pho M., Baker J., Walker M., Watson D., Hackett J. A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Breast Cancer Res. 2006, 8:R25.
15. Han L., Yuan Y., Zheng S., Yang Y., Li J., Edgerton M.E., Diao L., Xu Y., Verhaak R.G., Liang H. The Pan-cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes. Nat. Commun. 2014, 5.
16. Huang S., Yee C., Ching T., Yu H., Garmire L.X. A novel model to combine clinical and pathway-based transcriptomic information for the prognosis prediction of breast cancer. PLoS Comput. Biol. 2014, 10.
17. Ji P., Diederichs S., Wang W., Böing S., Metzger R., Schneider P.M., Tidow N., Brandt B., Buerger H., Bulk E. MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003, 22:8031-8041.
18. Iyer M.K., Niknafs Y.S., Malik R., Singhal U., Sahu A., Hosono Y., Barrette T.R., Prensner J.R., Evans J.R., Zhao S. The landscape of long noncoding RNAs in the human transcriptome. Nat. Genet. 2015, 47(3):199-208.
19. Kandoth C., Mclellan M.D., Vandin F., Ye K., Niu B., Lu C., Xie M., Zhang Q., Mcmichael J.F., Wyczalkowski M.A., Leiserson M.D., Miller C.A., Welch J.S., Walter M.J., Wendl M.C., Ley T.J., Wilson R.K., Raphael B.J., Ding L. Mutational landscape and significance across 12 major cancer types. Nature 2013, 502:333-339.
20. Khalil A.M., Guttman M., Huarte M., Garber M., Raj A., Morales D.R., Thomas K., Presser A., Bernstein B.E., Van Oudenaarden A. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl. Acad. Sci. 2009, 106:11667-11672.
21. Kowalczyk M.S., Higgs D.R., Gingeras T.R. Molecular biology: RNA discrimination. Nature 2012, 482:310-311.
22. Liang C.C., Park A.Y., Guan J.L. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc. 2007, 2:329-333.
23. Liao Q., Liu C., Yuan X., Kang S., Miao R., Xiao H., Zhao G., Luo H., Bu D., Zhao H. Large-scale prediction of long non-coding RNA functions in a coding-non-coding gene co-expression network. Nucleic Acids Res. 2011, 39:3864-3878.
24. Liao Y., Smyth G., Shi W. featureCounts: an efficient general-purpose read summarization program 2013, (arXiv, 1305, 16).
25. Liao Y., Smyth G.K., Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 2014, 30:923-930.
26. Ling H., Spizzo R., Atlasi Y., Nicoloso M., Shimizu M., Redis R.S., Nishida N., Gafà R., Song J., Guo Z. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 2013, 23:1446-1461.
27. Liu K., Yan Z., Li Y., Sun Z. Linc2GO: a human LincRNA function annotation resource based on ceRNA hypothesis. Bioinformatics 2013, 29:2221-2222.
28. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2- δδCT method. Methods 2001, 25:402-408.
29. Love M., Anders S., Huber W. Differential Analysis of RNA-Seq Data at the Gene Level Using the DESeq2 Package 2013.
30. Love M.I., Huber W., Anders S. Moderated estimation of fold change and dispersion for RNA-Seq data with DESeq2 2014, (bioRxiv).
31. Ma H., Hao Y., Dong X., Gong Q., Chen J., Zhang J., Tian W. Molecular mechanisms and function prediction of long noncoding RNA. Sci. World J. 2012, 2012.
32. Mchugh C.A., Russell P., Guttman M. Methods for comprehensive experimental identification of RNA-protein interactions. Genome Biol. 2014, 15:203.
33. Menor M., Ching T., Zhu X., Garmire D., Garmire L.X. mirMark: a site-level and UTR-level classifier for miRNA target prediction. Genome Biol. 2014, 15:500.
34. Penny G.D., Kay G.F., Sheardown S.A., Rastan S., Brockdorff N. Requirement for xist in X chromosome inactivation. Nature 1996, 379:131-137.
35. Prensner J.R., Iyer M.K., Balbin O.A., Dhanasekaran S.M., Cao Q., Brenner J.C., Laxman B., Asangani I.A., Grasso C.S., Kominsky H.D. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat. Biotechnol. 2011, 29:742-749.
36. Rinn J.L., Kertesz M., Wang J.K., Squazzo S.L., Xu X., Brugmann S.A., Goodnough L.H., Helms J.A., Farnham P.J., Segal E. Functional demarcation of active and silent chromatin domains in human < i > HOX loci by noncoding RNAs. Cell 2007, 129:1311-1323.
37. Rubie C., Kempf K., Hans J., Su T., Tilton B., Georg T., Brittner B., Ludwig B., Schilling M. Housekeeping gene variability in normal and cancerous colorectal, pancreatic, esophageal, gastric and hepatic tissues. Mol. Cell. Probes 2005, 19:101-109.
38. Salmena L., Poliseno L., Tay Y., Kats L., Pandolfi P.P. A < i > ceRNA hypothesis: the Rosetta Stone of a hidden RNA Language?. Cell 2011, 146:353-358.
39. Sun K., Chen X., Jiang P., Song X., Wang H., Sun H. iSeeRNA: identification of long intergenic non-coding RNA transcripts from transcriptome sequencing data. BMC Genomics 2013, 14:S7.
40. Trapnell C., Williams B.A., Pertea G., Mortazavi A., Kwan G., Van Baren M.J., Salzberg S.L., Wold B.J., Pachter L. Transcript assembly and quantification by RNA-seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 2010, 28:511-515.
41. Tripathi V., Ellis J.D., Shen Z., Song D.Y., Pan Q., Watt A.T., Freier S.M., Bennett C.F., Sharma A., Bubulya P.A. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell 2010, 39:925-938.
42. Ulitsky I., Bartel D.P. lincRNAs: genomics, evolution, and mechanisms. Cell 2013, 154:26-46.
43. Vitiello M., Tuccoli A., Poliseno L. Long non-coding RNAs in cancer: implications for personalized therapy. Cell. Oncol. 2014, 1-12.
44. Volinia S., Croce C.M. Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:7413-7417.
45. Wang K., Singh D., Zeng Z., Coleman S.J., Huang Y., Savich G.L., He X., Mieczkowski P., Grimm S.A., Perou C.M. MapSplice: accurate mapping of RNA-seq reads for splice junction discovery. Nucleic Acids Res. 2010, gkq622.
46. Wang L., Park H.J., Dasari S., Wang S., Kocher J.-P., Li W. CPAT: coding-potential assessment tool using an alignment-free logistic regression model. Nucleic Acids Res. 2013, 41:e74-e74.
47. Weakley S.M., Wang H., Yao Q., Chen C. Expression and function of a large non-coding RNA Gene XIST in human cancer. World J. Surg. 2011, 35:1751-1756.
48. Weinstein J.N., Collisson E.A., Mills G.B., Shaw K.R.M., Ozenberger B.A., Ellrott K., Shmulevich I., Sander C., Stuart J.M., Network C.G.A.R. The cancer genome atlas pan-cancer analysis project. Nat. Genet. 2013, 45:1113-1120.
49. Wilks C., Cline M.S., Weiler E., Diehkans M., Craft B., Martin C., Murphy D., Pierce H., Black J., Nelson D. The Cancer Genomics Hub (CGHub): overcoming cancer through the power of torrential data. Database 2014, 2014:bau093.
50. Yuan J., Wu W., Xie C., Zhao G., Zhao Y., Chen R. NPInter v2. 0: an updated database of ncRNA interactions. Nucleic Acids Res. 2014, 42:D104-D108.